{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-097949","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2026-08-17T21:27:41+00:00","discovered_at":"2026-08-17T21:30:01.030635+00:00","generated_at":"2026-08-17T21:30:11.859330+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Coherus closes $55M Innovatus term loan, repays prior 8%+SOFR facility due 2029","bullets":["Drew full $55M Tranche A on Aug 14, 2026; matures Aug 2031; rate 4.15% + greater of Prime or 6.75%.","Proceeds repaid prior senior secured facility (8.0% + 3-mo SOFR, due May 2029); remainder for working capital.","Interest-only for 36 months, extendable to 48 months upon revenue and market-cap milestones.","Optional tranches: $25M Term B (milestone-gated) and $20M Term C (lender discretion).","Prepayment fee 5% declining to 0% after year 3; final fee 4% (10% if DIP financing); facility fee 1.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-097949","json":"https://secwatch.observer/filing/0001104659-26-097949.json","markdown":"https://secwatch.observer/filing/0001104659-26-097949.md","text":"https://secwatch.observer/filing/0001104659-26-097949.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/0001104659-26-097949-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/chrs-20260817x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T21:30:11.859330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}